8,704 Shares in Tenet Healthcare Corporation $THC Purchased by Foster & Motley Inc.

Foster & Motley Inc. purchased a new position in Tenet Healthcare Corporation (NYSE:THC) during the second quarter, HoldingsChannel reports. The fund purchased 8,704 shares of the company’s stock, valued at approximately $1,628,000.

Other institutional investors have also added to or reduced their stakes in the company. Triumph Capital Management purchased a new position in shares of Tenet Healthcare in the third quarter worth $25,000. Activest Wealth Management purchased a new position in Tenet Healthcare during the fourth quarter valued at $26,000. Elyxium Wealth LLC purchased a new stake in Tenet Healthcare in the 4th quarter worth $29,000. Canada Pension Plan Investment Board bought a new position in shares of Tenet Healthcare during the 2nd quarter valued at about $35,000. Finally, Trust Co. of Vermont bought a new stake in shares of Tenet Healthcare in the second quarter worth about $37,000. 95.44% of the stock is owned by hedge funds and other institutional investors.

Tenet Healthcare Trading Down 0.4%

Shares of THC opened at $269.11 on Thursday. Tenet Healthcare Corporation has a twelve month low of $157.58 and a twelve month high of $277.76. The company has a current ratio of 1.41, a quick ratio of 1.35 and a debt-to-equity ratio of 2.00. The company’s fifty day simple moving average is $216.42 and its 200-day simple moving average is $205.69. The company has a market cap of $21.67 billion, a P/E ratio of 10.38, a P/E/G ratio of 1.03 and a beta of 1.23.

Tenet Healthcare (NYSE:THC) last issued its quarterly earnings results on Thursday, July 23rd. The company reported $6.12 EPS for the quarter, beating the consensus estimate of $4.26 by $1.86. The company had revenue of $6.04 billion for the quarter, compared to the consensus estimate of $5.43 billion. Tenet Healthcare had a net margin of 10.27% and a return on equity of 26.76%. The firm’s revenue was up 6.8% compared to the same quarter last year. During the same period in the prior year, the firm posted $4.02 EPS. Tenet Healthcare has set its FY 2026 guidance at 20.300-21.690 EPS. As a group, analysts expect that Tenet Healthcare Corporation will post 20.97 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of equities analysts recently commented on THC shares. Wells Fargo & Company increased their price target on Tenet Healthcare from $231.00 to $281.00 and gave the company an “overweight” rating in a research note on Monday, August 3rd. Royal Bank Of Canada boosted their price target on shares of Tenet Healthcare from $236.00 to $283.00 and gave the stock an “outperform” rating in a research report on Monday, July 27th. Raymond James Financial reissued an “outperform” rating and issued a $285.00 price objective on shares of Tenet Healthcare in a research note on Friday, August 14th. Cantor Fitzgerald reaffirmed an “overweight” rating on shares of Tenet Healthcare in a report on Monday, July 27th. Finally, Weiss Ratings downgraded Tenet Healthcare from a “buy (b-)” rating to a “hold (c+)” rating in a research report on Tuesday, June 2nd. One analyst has rated the stock with a Strong Buy rating, eighteen have given a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, Tenet Healthcare presently has an average rating of “Moderate Buy” and an average target price of $273.00.

Insider Transactions at Tenet Healthcare

In related news, Director Roy Blunt sold 600 shares of the firm’s stock in a transaction that occurred on Wednesday, August 5th. The stock was sold at an average price of $262.68, for a total transaction of $157,608.00. Following the completion of the sale, the director directly owned 4,589 shares of the company’s stock, valued at approximately $1,205,438.52. This trade represents a 11.56% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Lisa Y. Foo sold 10,000 shares of the company’s stock in a transaction on Wednesday, July 29th. The shares were sold at an average price of $258.03, for a total value of $2,580,300.00. Following the completion of the transaction, the executive vice president directly owned 32,053 shares in the company, valued at $8,270,635.59. This trade represents a 23.78% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders sold 41,375 shares of company stock valued at $9,793,347. Company insiders own 0.97% of the company’s stock.

Tenet Healthcare Company Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.